The Business Research Company’s market reports offer an in-depth analysis on the market’s growth potential, major drivers, key trends and more.

Market Overview: Strong Growth Trajectory

• Significant Market Expansion: The oxycodone drugs market has seen robust growth, with market size increasing from $5.25 billion in 2023 to an anticipated $5.62 billion in 2024, reflecting a CAGR of 7.0%.
• Historical Drivers: This growth is largely due to aggressive marketing campaigns, especially for OxyContin, which was heavily promoted for both chronic non-malignant pain and cancer-related pain. Post-World War II, the introduction of synthetic opiates like oxycodone further fueled market demand.

Future Outlook: Continued Growth and Innovations

• Forecasted Growth: The oxycodone drugs market is expected to grow to $7.41 billion by 2028, at a CAGR of 7.2%.
• Key Growth Drivers:
  • Increasing prevalence of chronic pain.
  • Rising number of surgical procedures.
  • Advancements in drug delivery systems.
  • A growing elderly population, which experiences higher incidences of chronic pain.
• Emerging Trends:
  • Development of abuse-deterrent formulations (ADFs).
  • Innovations in drug delivery systems.
  • Growing use of combination therapies.
  • Technological advancements in manufacturing.

Read More On The Oxycodone Drugs Market Report 2024 – https://www.thebusinessresearchcompany.com/report/oxycodone-drugs-global-market-report

Orthopedic Disorder Surge Fuels Market Growth

• High Burden of Orthopedic Disorders: The rising incidence of orthopedic conditions due to aging populations, sedentary lifestyles, and other factors is driving demand for oxycodone drugs.
• Impact on Market:
  • Oxycodone is used to alleviate pain from fractures, joint injuries, and post-surgical discomfort.
  • A significant increase in musculoskeletal disorders is expected, with projected cases rising by 115% from 2020 to 2050, reaching over 1 billion cases by 2050.

Focus on Developing Immediate-Release Tablets to Combat Drug Abuse

• Innovative Drug Development: Companies in the oxycodone market are focusing on creating formulations that reduce the potential for abuse.
• Key Example:
  • In July 2022, Protega Pharmaceuticals launched RoxyBond, an FDA-approved immediate-release oxycodone tablet designed to deter abuse through physical and chemical resistance.

UNC Kenan-Flagler and Acadia Healthcare Partner to Combat Opioid Crisis

• Strategic Partnership: In February 2023, UNC Kenan-Flagler Business School and Acadia Healthcare collaborated to create an opioid settlement playbook, aiming to guide communities in effectively using funds from opioid settlements.
• Objective:
  • The partnership focuses on optimizing the use of settlement funds for opioid recovery efforts, particularly in communities affected by the opioid crisis.

Market Segmentation and Regional Insights

• Segmentation:
  • By Drug Type: Short-acting oxycodone, long-acting oxycodone.
  • By Dosage Form: Tablets, capsules, injections.
  • By Indication: Neuropathic pain, musculoskeletal pain, cancer pain, post-operative pain, other indications.
  • By Distribution Channel: Hospital pharmacies, retail pharmacies, online pharmacies.
• Regional Insights:
  • North America was the largest market in 2023.
  • Asia-Pacific is expected to be the fastest-growing region during the forecast period.

Key Players in the Market

• Leading Companies: The market is dominated by major pharmaceutical players such as Pfizer Inc., Johnson & Johnson, Teva Pharmaceutical Industries, Purdue Pharma, and others.

The oxycodone drugs market is set for significant growth, driven by increasing demand due to chronic pain, innovations in drug delivery, and strategic partnerships aimed at addressing the opioid crisis.

Request for A Sample Of The Global Oxycodone Drugs Market Report:
https://www.thebusinessresearchcompany.com/sample_request?id=15886&type=smp